Related Experiment Video
Updated: Jul 15, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
[Epigenetic processes in malignant transformation: the role of DNA methylation in cancer development]
K P M Suijkerbuijk1, E van der Wall, T van Laar
1Afd. Pathologie, Universitair Medisch Centrum Utrecht, Postbus 85.500, 3508 GA Utrecht. k.suijkerbuijk@umcutrecht.nl
Abstract:
Defects in DNA that activate oncogenes or inactivate tumour-suppressor genes are regarded as a crucial step in tumour development. Understanding the processes that modulate gene activity, the so-called epigenetic processes, is gaining importance in the search for factors responsible for uncontrolled cell growth. Cell proliferation is determined by epigenetic and genetic processes. Abnormal patterns of methylation and other epigenetic processes, such as acetylation, nucleosome formation and compact chromatin structure, can suppress transcription and inactivate tumour-suppressor genes. Methylation status is a promising biomarker for malignancy because the process is not patient-specific, it occurs at an early stage oftumour development and may precede morphological changes.
Insights
Epigenetic processes, like DNA methylation, are crucial in tumor development by controlling gene activity. Aberrant methylation patterns can inactivate tumor-suppressor genes, making methylation status a key biomarker for early cancer detection.
Area of Science:
- Molecular Biology
- Genetics
- Epigenetics
Context:
- Tumorigenesis involves genetic and epigenetic alterations.
- Epigenetic processes critically regulate gene expression.
- Understanding these mechanisms is vital for cancer research.
Purpose:
- To highlight the role of epigenetic processes in tumor development.
- To emphasize the significance of DNA methylation as a biomarker.
- To explore how epigenetic changes influence oncogene and tumor-suppressor gene activity.
Summary:
- Defects in DNA, including oncogene activation and tumor-suppressor gene inactivation, are key to tumor formation.
- Epigenetic mechanisms, such as DNA methylation and histone acetylation, modulate gene activity and cell proliferation.
- Abnormal methylation patterns can lead to the silencing of tumor-suppressor genes, contributing to cancer development.
Impact:
- DNA methylation patterns serve as promising biomarkers for malignancy.
- Methylation is an early event in tumorigenesis, potentially preceding morphological changes.
- This understanding aids in developing novel diagnostic and therapeutic strategies for cancer.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

